Lou Fuqua

MedShape, Inc. develops and commercializes a portfolio of surgical solutions that use patented material technologies. It offers ExoShape soft tissue fasteners for fixation of the soft tissue graft on the tibial side of the knee joint in anterior cruciate ligament (ACL)reconstructions; and The ExoShape teno soft tissue fasteners for the fixation of connective soft tissues (tendons and ligaments) to bone during tenodesis, tendon transfer, and ligament reconstruction procedures in the extremities. The company was founded by Douglas J. Pacaccio and Kenneth A. Gall in 2005 and is headquartered in Atlanta, GA.

AvidXchange, Inc. engages in the provision of end-to-end automated accounts payable solutions. It offers specialized services and analytics, accounting systems integrations. The firm serves mid-sized companies in the real estate, banking, and healthcare industries. The company was founded by Michael S. Praeger, Chris Tinsley, David Miller, and Chris Coutinho in April 2000 and is headquartered in Charlotte, NC.

MRI Software LLC engages in the provision of real estate investment software for commercial and residential property managers. Its products are used for property management, financials and accounting, and investment management. The company was founded by Fred Goodman and Sid Goodman in 1971 and is headquartered in Solon, OH.

InnAVasc Medical, Inc. designs and develops products for vascular access for hemodialysis. Its technology vascular access graft is designed to create one contiguous flow lumen without transition points. The company is headquartered in Durham, NC.

restor3d, Inc. provides health care services. The company was founded in 2017 and is headquartered in Durham, NC.

Cersci Therapeutics, Inc. operates as pharmaceutical company. The firm develops non-opioid analgesic drug products without the deleterious side effects. The company was founded by Lucas Rodriguez and Brent Duncan in 2019 and is headquartered in Dallas, TX.

Sparta Biomedical, Inc. has developed a breakthrough device called ORMI™ to treat knee osteoarthritis. The company is based in Madison, NJ. The device has been granted breakthrough device designation by the FDA. The company is committed to improving motion, reducing pain, and increasing the quality of life of patients with osteoarthritis. ORMI™ is different from other technologies that focus on cartilage regeneration approaches, which can take a long time to grow and not be as strong as the original. The company was founded by Dushyanth Surakanti and Dimitrios Angelis, and Dushyanth Surakanti has been the CEO since incorporation.